We are glad to inform you that OMNIA 2.0, the most comprehensive Data Management software for Metabolic, Lung Function and Body Composition Assessment has been released. OMNIA 2.0 development has been a significant effort both financially and in term of manpower. However beside implementing a number of features that will position significantly ...

Rome - May 31, 2021 COSMED, a worldwide leader in the design of metabolic systems for clinical and human performance applications, was a winner of this year’s iF DESIGN AWARD, with the Metabolic Monitor Q-NRG. Each year, the world’s oldest independent design organization, Hannover-based iF International Forum Design GmbH, organizes the iF DESI...

Progetto ReStart Cofinanziato dall'Unione Europea - www.europa.eu Avviso Pubblico “PROGETTI DI INTERNAZIONALIZZAZIONE” di cui alla Det. n. G18225 del 20/12/2019 - POR FESR LAZIO 2014-2020 – CUP F19J21000140007 – Domanda prot. n. A0350-2020-35767 codice prog. POR A0350E0095 COR 4866242. Progetto approvato con Determinazione n. G02541 del 09/03/...

Rome - April 27, 2021 COSMED, a worldwide leader in the design of metabolic systems for clinical and human performance applications, was a winner of this year’s Red Dot Award, with the Metabolic Monitor Q-NRG. This Product Design competition has existed since 1954. Its award, the Red Dot, is an internationally recognised quality seal. Only pro...

COSMED announces new distribution partnership for the Chinese market from January 1st 2021. COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has appointes Beijing Medical Technology Co.Ltd as general agent for the Chinese market.    意大利科时迈公司 中国市场总代理变更公告 意大利科时迈公司（COSMED Srl）正式声明自2021年1...

Best wishes for Christmas Season from COSMED family! In this unusually difficult Holiday Season, we wish you a safe Christmas in a quiet and cozy corner with your family and friends! We all know that 2020 has certainly been a very challenging year for everyone, both privately and professionally and we can only hope that 2021 will be better. We...

COSMED introduces BOD POD GS-X, the 4th generation of the world’s first and only Air Displacement Plethysmograph (ADP), the Gold Standard for two compartment Body Composition model. COSMED, world-wide leader manufacturer of Cardiopulmonary, Metabolic and Body Composition diagnostic equipment for clinical and human performance applications, an...

COSMED wins the award "Best company on stage", the recognition delivered every year by Campus Bio-Medico University in Rome to those companies that have made possible a positive collaboration with the University for welcoming the largest number of trainees. "The idea is to give recognition to those who help us to complete our training course wi...

Progetto Q-NRG INT-P Cofinanziato dall'Unione Europea - www.europa.eu Avviso Pubblico “Voucher Internazionalizzazione” di cui alla Det. n. G10195 del 26/07/2019 - POR FESR LAZIO 2014-2020 – CUP F14E20000090007 – Domanda prot. n. A0331-2019-31351 Progetto approvato con Determinazione n. G02590 del 06/03/2020 pubblicata sul BURL n. 23 del 10/03/...

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max)....

The FDA has granted marketing approval for the device in the US market where we expect to launch the product during the next ASPEN 2020 Nutrition conference taking place in Tampa, FL on March 28-31. Q-NRG is a result of COSMED’s collaboration with world-class institutes in the field of nutrition support in intensive care units. Product concept ...

During these exceptional times, we would like to inform you that COSMED is adapting to the COVID-19 situation with diligence and is trying to face this big challenge with determination. We wanted to take a moment to share with our customers, partners and communities how COSMED is responding to this evolving situation. Supporting our people and...

COSMED Srl, a worldwide leader in the design of metabolic systems for clinical and human performance applications and Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, today announced an agreement to commercialize Q-NRG+, a metabolic monitoring device utilizing indirect calorimetry technology. The agreement provides ...

Rome (Italy) - March 2018 - COSMED, world-wide leader in the design of metabolic systems for clinical and human performance applications, announced today the release of a new product line of metabolic monitors for quick, accurate, intuitive and affordable indirect calorimetry. Q-NRG is the ultimate tool to understand how to support a patient ac...

Finanziamento FESR per lo sviluppo di un innovativo calorimetro stand-alone Spartacus: Un progetto cofinanziato dall'Unione Europea (FESR) Un progetto cofinanziato dall'Unione Europea (FESR) COSMED ha beneficiato di finanziamenti del Fondo Europeo di Sviluppo Regionale (FESR) per lo sviluppo di un innovativo calorimetro stand-alone per la mi...

Concord (California, USA) - November 2017 - COSMED announced its K5 Wearable Metabolic System has received a 2017 Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the country. The designation was based on direct feedback from hospital experts who interacted with the K...

Rome (Italy) - November 2017 - COSMED, leader in cardiopulmonary and metabolic diagnostics, is proud to announce the incorporation of COSMED Benelux BV. The new company has been incorporated further to the assets acquisition of TulipMed BV, the COSMED long-established Dutch distributor. COSMED Benelux BV will cover Netherlands and Luxembourg an...

Rome (Italy) - September 2017 - The European Patent Office (EPO) has produced a series of case studies on European small and medium-sized enterprises (SMEs) which are leveraging the power of patents and other Intellectual Property (IP) rights to achieve business success. COSMED has been chosen to be interviewed about its IP strategies and how t...

Rome (Italy) - May 2017 - We are glad to inform you that COSMED has recently signed an agreement with BOSCH Healthcare Solutions GmbH for the distribution of their new FeNO device. The new Vivatmo device, manufactured from Bosch Healthcare, measures the NO-content in exhaled breath. FeNO (fractional exhaled nitric oxide) is a biomarker for eosi...

COSMED is glad to inform that, starting from the 17th of February, the new 1.6 release of OMNIA is available for download to registered users. COSMED recommends to upgrade existing systems as the unit resolves also some bugs. Together with additional features and general improvements, OMNIA 1.6 introduces new important tests including Rocc, P0....

COSMED is glad to inform that, starting from the 2nd of May, the new 1.5 release of OMNIA is available for download to registered users. COSMED recommends to upgrade existing systems as the unit resolves also some bugs. Together with additional features and general improvements, OMNIA 1.5 introduces new important modules including Lung Volumes ...